Answers are grounded in this paper and cite their sources.
Analysis shows no reduction in mortality or liver failure in mushroom poisoning with oral silymarin, but suggests lower kidney injury.
We were unable to demonstrate a reduction in mortality, acute liver failure, or hospital length of stay associated with oral silymarin use. However, it appeared to decrease the incidence of acute kidney injury.
No takes yet. Share an insight, caveat, or question.
Tangsuwanaruk et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: